Literature DB >> 2551317

Vasopressin receptor subtypes: autoradiographic localization of V1 vasopressin binding sites in rat brain and kidney.

F Fahrenholz1, R Gerstberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2551317     DOI： 10.1007/BF01674283

Source DB:  PubMed          Journal:  J Protein Chem        ISSN： 0277-8033


× No keyword cloud information.
  18 in total

1.  Photoaffinity labeling of the V1 vasopressin receptor in plasma membranes from rat liver.

Authors:  R Boer; F Fahrenholz
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

2.  A mechanism for vasopressin action in the hippocampus.

Authors:  D Albeck; T Smock
Journal:  Brain Res       Date:  1988-11-01       Impact factor: 3.252

3.  Interaction of rat adenohypophyseal vasopressin receptors with vasopressin analogues substituted at positions 7 and 1: dissimilarity from the V1 vasopressin receptor.

Authors:  W Knepel; D Götz; F Fahrenholz
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

4.  Prostaglandin E2 and cyclic AMP response to vasopressin in renal medullary tubular cells.

Authors:  R P Wuthrich; M B Vallotton
Journal:  Am J Physiol       Date:  1986-09

5.  Vasopressin V1 receptors on the principal cells of the rabbit cortical collecting tubule. Stimulation of cytosolic free calcium and inositol phosphate production via coupling to a pertussis toxin substrate.

Authors:  M A Burnatowska-Hledin; W S Spielman
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

6.  Interactions of vasopressin agonists and antagonists with membrane receptors.

Authors:  F Fahrenholz; R Boer; P Crause; G Fritzsch; Z Grzonka
Journal:  Eur J Pharmacol       Date:  1984-04-13       Impact factor: 4.432

7.  Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin.

Authors:  L R Chase; G D Aurbach
Journal:  Science       Date:  1968-02-02       Impact factor: 47.728

8.  Influence of sarcosine or N-methylalanine in position 7 on the antagonistic properties of [1-deaminopenicillamine]- and [1-(beta-mercapto-beta, beta-cyclopentylmethylene-propionic acid)]-vasopressin.

Authors:  D Gazis; I L Schwartz; B Lammek; Z Grzonka
Journal:  Int J Pept Protein Res       Date:  1984-01

9.  Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography.

Authors:  E Tribollet; C Barberis; S Jard; M Dubois-Dauphin; J J Dreifuss
Journal:  Brain Res       Date:  1988-02-23       Impact factor: 3.252

10.  Evidence for vasopressin V1 receptors of rostrodiencephalic neurons: iontophoretic studies in the in vivo rat. Responses to oxytocin and to angiotensin.

Authors:  A C Jeulin; S Nicolaidis
Journal:  Brain Res Bull       Date:  1988-06       Impact factor: 4.077
View more
  2 in total

1.  The effects of analogs of the C-terminal fragment of arginine-vasopressin on the dynamics of development of a conditioned active avoidance response in rats.

Authors:  O G Voskresenskaya; S A Titov; A A Kamenskii; V P Golubovich; I P Ashmarin
Journal:  Neurosci Behav Physiol       Date:  1999 Mar-Apr

2.  Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand.

Authors:  Sylvia Chen; Matthew J Webber; Jean-Pierre Vilardaga; Ashok Khatri; Dennis Brown; Dennis A Ausiello; Herbert Y Lin; Richard Bouley
Journal:  Endocrinology       Date:  2011-08-09       Impact factor: 4.736
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.